Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

• ESGold Corp., a development-stage company, committed to the acquisition, exploration, and development of high-quality mineral properties worldwide, just announced a binding purchase agreement for 44 additional mineral claims in the Montauban region
• The additional claims total approximately 2,448 hectares, and will add to the 417 mining claims across 20,618 hectares previously controlled
• It marks a key milestone for the company to tap Montauban’s true gold-silver potential and bring it to production this year

ESGold (CSE: ESAU) (OTCQB: ESAUF), a development-stage company committed to acquiring, exploring, and developing high-quality mineral properties worldwide, just announced a binding purchase agreement for the acquisition of 44 additional mineral claims in the Montauban region of Québec. The additional claims total approximately 2,448 hectares, adding to its 417 mining claims covering 20,618 hectares that it previously controlled (https://ibn.fm/zZ6B1).

The acquisition involved a total consideration of $70,000 in cash, and 600,000 common shares at a deemed price of $0.50 a share, with a deemed value of $300,000.

“These acquisitions reflect our disciplined approach to building a district-scale exploration opportunity at Montauban,” noted ESGold’s CEO, Gordon Robb. “As our geological understanding evolves through ongoing data integration and interpretation, securing additional prospective ground positions us to systematically evaluate targets and advance exploration in a structured manner,” he added (https://ibn.fm/zZ6B1).

Back in February 2026, ESGold released findings from its ambient noise tomography (“ANT”) based 3D geological model. The results pointed to a deep, laterally extensive anomaly that suggested the potential for a mineralized corridor extending to approximately 900 meters depth and over two kilometers of strike. Most notably, the findings noted that the corridor would extend beyond the limits of the existing survey area at the property (https://ibn.fm/v0mZE).

Findings from this study informed the new acquisitions and further complement the historically documented polymetallic mineralization, with potential to generate a sizable and sustainable revenue stream for ESGold for many years to come. 

While speaking on an episode of The MiningNewsWire Podcast, Robb was keen to note that 2026 would be a big year for the company. With decent progress on the development of its facility and its goal to be in operations within the year, ESGold was already well-positioned for success. The acquisition of the additional mining claims further bolsters the company’s position, not just in the Montauban region but also globally. In addition, it brings the company closer to realizing the full potential of this mine, with a history that dates back over 100 years.

“This is a past-producing mine that produced for well over 100 years, yet with very limited property-wide exploration. We have a lot of milestones coming up, and at the same time, we’re developing, exploring, and aiming to be producing all in the same year,” Robb noted (https://ibn.fm/VCeLn).

For company information, visit the company’s website at www.ESGold.com.

NOTE TO INVESTORS: The latest news and updates relating to ESAUF are available in the company’s newsroom at https://ibn.fm/ESAUF

• Beeline reported Q1 2026 revenue of $2.7 million, up over 100% year-over-year for its growing digital mortgage platform.
• Loan originations increased to $85.6 million across 288 loans, compared with $39.8 million a year earlier.
• Management continues to target a $100 million revenue run rate exiting 2027, while emphasizing cost controls and operating leverage.
• The company is expanding its capital-light BeelineEquity platform, which generates fee revenue without balance sheet exposure.
• AI tools, including Beeline’s “Bob” chatbot and automation platform, are being used to improve prospective borrower conversion rates and reduce processing times.

Beeline Holdings (NASDAQ: BLNE), with its fast-growing digital mortgage platform offering a quicker and easier path to homeownership, reported first-quarter 2026 results that showed accelerating revenue growth alongside a broader strategic push into fee-based housing finance products and AI-enabled automation. The company said quarterly revenue reached $2.7 million, more than doubling from the prior-year period. Loan originations climbed to $85.6 million across 288 loans, compared with $39.8 million across 128 loans a year earlier.

Beeline’s diversified platform includes both conventional and certain Non-QM Mortgages, such as DSCR & Bank Statements loans, along with its new Equity Product (“BeelineEquity”) and Title Services. The company stated that it will shift its marketing efforts to drive the higher margin Non-Qm products which have positive loan economics and currently represent over half of its business.

Chief Executive Officer Nick Liuzza told investors during the earnings call that the company is prioritizing profitable transactions over raw origination volume amid continued uncertainty surrounding interest rates, inflation and capital markets. “We are leaning into the parts of the business that already work,” Liuzza said during the call, while emphasizing expense reductions and capital efficiency initiatives.

Operating expenses totaled $7.9 million during the quarter, including roughly $1 million in stock-based compensation. Net loss narrowed to $5.3 million from $6.9 million in the comparable quarter last year, while adjusted EBITDA loss improved to $3 million from $3.8 million. Management said the company has implemented cost reductions expected to lower annualized expenses by roughly $2.5 million.

The marketing shift to the Non-Qm Products is complemented by its unique equity Product, BeelineEquity, which also has stronger margins with a much lower cost to deliver, since the underwriting revolves around the property and not the individual. The company stated that it is not moving away from the conventional business but is focused on higher revenue and stronger margins. 

Liuzza said BeelineEquity generates approximately 3.5% of transaction value in fees, along with additional title revenue averaging about $1,500 per transaction. Unlike conventional lending operations, the company said the platform carries no balance sheet exposure.

The executive team repeatedly framed BeelineEquity as an attempt to address a large untapped market. During the conference call, management cited Federal Reserve estimates showing roughly $35 trillion in U.S. homeowner equity, much of which remains inaccessible without refinancing or borrowing. The company believes that dynamic may become increasingly relevant as higher interest rates discourage homeowners from refinancing existing mortgages.

Beeline’s operating strategy also reflects broader demographic trends shaping the housing market. The company has increasingly targeted millennial and Gen Z borrowers, particularly gig economy workers and real estate investors who may not fit conventional underwriting standards. According to reporting from National Mortgage Professional, homeownership rates among younger demographics remain constrained by affordability and mortgage qualification barriers.

Management argues that automation and AI-assisted underwriting can help address those bottlenecks. Chief Operating Officer Jess Kennedy said the company’s AI-enabled systems are improving operational efficiency and conversion rates. The company’s chatbot, known internally as Bob, reportedly increases lead-to-lock conversion rates by roughly 8% when engaged with prospective borrowers through digital channels.

Kennedy also said Beeline’s self-service mortgage workflow has produced a 131% increase in application-to-lock pull-through during early deployment phases.

The company has concentrated much of its lending activity in higher-margin non-qualified mortgage categories, including debt-service coverage ratio loans and bank-statement lending products. Conventional mortgages remain part of the platform, though management indicated those products are becoming less central to its growth strategy.

In parallel, Beeline continues investing in adjacent technology operations. The company maintains a minority stake in MagicBlocks, an AI-driven sales platform that supports portions of Beeline’s internal technology stack. Management disclosed during the conference call that MagicBlocks has recently onboarded several major lenders, including one top-10 lender.

Beeline also recently announced a partnership with Structured Real Estate Group in Dallas, which management expects will begin contributing revenue during the second half of 2026. The company said the arrangement involves embedding Beeline’s financing platform into the builder’s digital sales infrastructure, with an initial geographic focus on Texas and broader expansion potential across the Southeast.

Beeline ended the quarter with $1.9 million in cash, $50.9 million in shareholder equity and no corporate debt.

The broader U.S. mortgage sector remains pressured by elevated borrowing costs and uneven housing demand. Beeline’s strategy, however, attempts to reduce direct dependence on mortgage spreads by expanding recurring fee-based and technology-driven revenue streams.

Liuzza reiterated that the company’s goal of reaching a $100 million revenue run rate by the end of 2027 remains a target rather than a guarantee. Still, management framed the first quarter as evidence that the platform’s operating model is beginning to gain traction as Beeline attempts to build a more diversified housing finance business anchored by automation, equity-access products and AI-enabled customer acquisition. “Our platform is unique. We built the platform combining mortgage, title, BeelineEquity, and AI, all under one roof. Each piece reinforces the others,” Liuzza added.

For more information, visit the company’s website at www.MakeABeeline.com.

NOTE TO INVESTORS: The latest news and updates relating to BLNE are available in the company’s newsroom at https://ibn.fm/BLNE

• Agreement outlines an exclusive patent license granted to Wellgistics Health, giving the company sole access within its market segment to Datavault AI’s proprietary technologies.
• At the center of the initiative is PharmacyChain(TM), a platform designed to track and manage prescription fulfillment from manufacturer to patient while automating processes that are traditionally routed through PBMs.
• By granting exclusive, Datavault AI creates a stronger commercial incentive for adoption while also reinforcing the value of its intellectual property portfolio.

Prescription drug prices in the United States are among the highest in the world, driven in part by complex rebate structures controlled by pharmacy benefit managers (“PBMs”). Datavault AI (NASDAQ: DVLT), a technology company focused on AI-driven data monetization and digital asset infrastructure, is entering this landscape through an exclusive licensing agreement with Wellgistics Health Inc. The agreement positions the company’s technology at the center of a platform designed to streamline prescription distribution and reduce reliance on traditional intermediaries.

According to the company, the agreement outlines an exclusive patent license granted to Wellgistics Health, giving the company sole access within its market segment to Datavault AI’s proprietary technologies. This exclusivity is a defining feature of the agreement, as it prevents direct competitors from deploying the same intellectual property and establishes a differentiated position for Wellgistics within the pharmaceutical distribution ecosystem.

At the center of the initiative is PharmacyChain(TM), a platform designed to track and manage prescription fulfillment from manufacturer to patient while automating processes that are traditionally routed through PBMs. Rather than functioning as a conceptual blockchain layer, PharmacyChain is built on an existing operational foundation. Wellgistics already connects more than 6,500 independent pharmacies and over 200 pharmaceutical manufacturers, providing an established distribution network capable of supporting immediate deployment. The system is further supported by the EinsteinRx AI hub, which has already been completed and is designed to integrate analytics, automation and data-driven decision-making into prescription workflows.

The significance of this structure lies in its potential to reduce reliance on traditional intermediary models within pharmaceutical distribution. The companies describe PharmacyChain as a platform designed to track prescriptions across the supply chain while minimizing dependence on rebate-driven systems, positioning it as a more transparent and efficient alternative to conventional frameworks.

Leadership commentary from Wellgistics reinforces this objective. The company has emphasized that minimizing or eliminating PBM-related rebate structures is a central goal of its initiative, framing the PharmacyChain platform not simply as a technological upgrade but as a structural change to how prescription drugs are distributed and priced. Additional insight from Wellgistics president and interim CEO, Prashant Patel, RPh, also highlights the role of the company’s technology leadership, including expertise drawn from prior experience at OptumRx, one of the largest PBM organizations in the United States. 

“By minimizing or eliminating PBM rebates for pharmacies and manufacturers while reducing administrative burden for payers, Wellgistics intends to disrupt and revolutionize the path through which prescription drugs are dispensed in the United States,” said Patel. “Further, given our CTO Srini Kalla’s background at OptumRX, we now possess all the ingredients necessary to develop new ways to reduce patients’ out-of-pocket costs by empowering them with the ability to monetize their data to manufacturers or other stakeholders within the healthcare system.”

From Datavault AI’s perspective, the agreement represents more than a single deployment. It is part of a broader strategy centered on licensing proprietary technology into regulated industries where data integrity, compliance and traceability are critical. The company’s platform is designed to convert real-world interactions and assets into structured, verifiable digital records that can support analytics, automation and monetization. In the context of healthcare, this capability extends to prescription tracking, identity verification and secure data exchange, all of which are essential in highly regulated environments.

The exclusivity of the Wellgistics license is particularly important within this strategy. By granting exclusive rights rather than entering into a nonexclusive partnership, Datavault AI creates a stronger commercial incentive for adoption while also reinforcing the value of its intellectual property portfolio. This approach mirrors a broader pattern in the company’s recent activity, where proprietary technologies are deployed through structured agreements that emphasize long-term monetization rather than one-time implementations.

Recent financial results provide additional context for the significance of this agreement. Datavault AI reported its first profitable quarter in its fiscal year 2025 results, with revenue reaching $39.1 million, representing a 1,362% increase year over year. The company has also indicated a trajectory toward substantially higher revenue in 2026, supported by a growing pipeline of licensing agreements and tokenization initiatives. Within that framework, the Wellgistics agreement stands out as an example of how the company is extending its platform into large, regulated markets with significant economic impact.

The collaboration also illustrates a broader convergence between healthcare infrastructure and advanced data systems. As the industry continues to evolve, stakeholders are increasingly focused on improving transparency, reducing inefficiencies and enabling more direct relationships between manufacturers, pharmacies and patients. By integrating Datavault AI’s technology into an existing network of pharmacies and manufacturers, the Wellgistics platform represents an attempt to operationalize those goals in a way that is both scalable and compliant.

While the long-term impact of PharmacyChain will depend on adoption and execution, the structure of the agreement provides a clear indication of intent. This is not a general technology partnership but an exclusive licensing arrangement tied to a defined platform with an existing network, a completed AI infrastructure layer and a specific target in addressing PBM-related inefficiencies. For Datavault AI, it represents another step in positioning its technology as an infrastructure layer within industries where data, compliance and monetization intersect.

For more information, visit www.DVLT.ai.

NOTE TO INVESTORS: The latest news and updates relating to DVLT are available in the company’s newsroom at https://ibn.fm/DVLT

• Growing AI adoption is increasing pressure on global computing and energy infrastructure, leading many organizations to manage limited resources, adjust deployment timelines, and navigate rising costs
• Industry reports indicate that compute capacity and supporting power infrastructure are tightening as demand accelerates
• BluSky AI is developing modular data center systems intended to support faster deployment, scalable capacity, and GPU-as-a-Service access

The rapid expansion of artificial intelligence is revealing a structural challenge that extends beyond software development. As AI usage increases across sectors—including automation, content generation, and enterprise-scale digital agents—the availability of high-performance compute and the energy required to operate it has become a central constraint.

Recent industry reporting has highlighted that AI workloads require substantial electricity and high-density compute environments, contributing to capacity limitations in certain regions. In many cases, access to compute is tightening, and timelines for new infrastructure can extend multiple years. As a result, discussions around AI are increasingly focused on the underlying infrastructure required to support continued adoption.

A significant driver of this demand is the rise of “agentic AI” a category of systems capable of performing multi-step tasks such as research, scheduling, and workflow automation with minimal human input. These workloads can increase compute intensity per user, and as enterprises integrate these tools into core operations, demand for high-performance compute and reliable power continues to grow.

While these constraints present challenges, they also highlight the need for deployment models that can be executed more quickly than traditional data center development, which is often influenced by permitting, grid access, and capital requirements.

Modular data center approaches are emerging as one potential pathway. By enabling infrastructure to be prefabricated, transported, and installed near power sources or end users, modular systems may help address bottlenecks in both compute availability and energy distribution.

BluSky AI (OTC: BSAI) is among the companies pursuing this direction. The company is developing modular data center solutions designed to address the widening gap between AI compute demand and available infrastructure.

BluSky AI’s SkyMod architecture consists of pre-assembled, scalable units engineered for AI-specific workloads. According to the company, the SkyMod One is expected to support approximately 1 MW of compute capacity within a 1,400-square-foot footprint, while the SkyMod XL is designed for approximately 1.7 MW within roughly 3,000 square feet. Management has stated that a 50,000-square-foot footprint is the average for a planned 15 MW site. By comparison, traditional data centers can require significantly larger footprints depending on design and use case.

The company emphasizes that “modular” refers to the construction and deployment method rather than mobility. Each SkyMod unit is a steel-reinforced structure—approximately 13 feet wide by 50 feet long—built in a controlled environment and delivered as a hardened facility with integrated security features. Multiple SkyMods can be interconnected to create sites ranging from 2 MW to an anticipated 50 MW of AI-focused compute capacity.

BluSky AI’s long-term vision includes what it describes as a “Distributed Neocloud,” a planned network of modular sites positioned across the United States. According to the company, this network is intended to support inference-driven applications such as surgical assistance, autonomous systems, and real-time customer service, which may benefit from distributed, low-latency compute.

As AI adoption continues to expand, infrastructure remains a central theme for enterprises seeking reliable access to compute resources. Solutions that can be deployed more quickly or scaled more flexibly may attract increasing attention as organizations evaluate options for meeting their operational needs. For companies working at this intersection, current constraints may represent an environment where new infrastructure models could play a meaningful role.

For additional information, visit BluSkyAIDataCenters.com.

NOTE TO INVESTORS: Updates and news related to BSAI can be found in the company’s newsroom at https://ibn.fm/BSAI.

• CDIO’s vision reflects a broader shift taking place across the healthcare industry toward predictive and Precision Medicine.
• Achieving that goal requires a combination of scientific expertise, advanced technology, scalable testing and improved accessibility.
• Cardio Diagnostics’ focus on innovation is particularly relevant in cardiovascular disease, where earlier identification of risk factors can significantly influence outcomes.

Heart disease remains the leading cause of death worldwide, yet much of modern healthcare still focuses on reacting to cardiovascular events after they occur rather than identifying risk earlier and preventing disease progression. Cardio Diagnostics Holdings (NASDAQ: CDIO) is working to help reshape that paradigm through a vision centered on personalized, data-driven cardiovascular care powered by artificial intelligence, epigenetics and genetic insights. Through its proprietary platform and expanding testing capabilities, the company is pursuing a future in which prevention becomes more accessible, scalable and actionable before life-threatening cardiac events occur.

The company’s vision reflects a broader shift taking place across the healthcare industry toward predictive and Precision Medicine. Cardio Diagnostics envisions a healthcare system where every patient receives individualized care informed by their unique molecular insights and where heart disease is no longer the world’s leading killer. Achieving that goal requires a combination of scientific expertise, advanced technology, scalable testing and improved accessibility, all areas the company has identified as foundational pillars of its strategy.

One of the central themes emphasized by Cardio Diagnostics is expert-led innovation. The company operates at the intersection of biotechnology, data science and cardiovascular medicine, bringing together expertise across multiple disciplines to develop its AI-driven diagnostic platform. This multidisciplinary approach is increasingly important as healthcare systems seek to integrate molecular data, including epigenomic and genomic, into clinical decision-making.

Cardio Diagnostics’ focus on innovation is particularly relevant in cardiovascular disease, where earlier identification of risk and disease can significantly influence outcomes. Heart disease remains the leading cause of death in the United States, with more than 800,000 Americans experiencing a heart attack every year, accounting for approximately one in every five deaths. For many, a heart attack is the first sign of coronary heart disease. These statistics underscore the need for more proactive approaches to cardiovascular care, especially tools capable of identifying disease risk before symptoms emerge.

The company’s next-generation technology platform is designed to address this need by using artificial intelligence (“AI”) to integrate multi-omic data, specifically epigenetic markers such as DNA methylation, with genetic information, to provide a more comprehensive view of cardiovascular health. Cardio Diagnostics integrates this information to generate individualized cardiovascular risk assessments from a simple blood sample.

Dynamic biomarkers represent a key component of the company’s strategy. Traditional cardiovascular risk assessments often rely on indicators such as cholesterol levels and blood pressure. While important, these measurements may not fully capture how environmental exposures, lifestyle factors and biological changes influence disease progression over time. Cardio Diagnostics’ platform incorporates epigenetic biomarkers, which can reflect how behaviors, lifestyle and environmental factors alter gene expression.

Research indicates that DNA methylation patterns can reflect environmental exposures and lifestyle influences while also serving as early indicators of disease risk. Because epigenetic markers can change over time, they offer a more dynamic perspective on cardiovascular health than static genetic information alone. Cardio Diagnostics leverages this capability to provide molecular insights intended to support earlier intervention and more personalized care planning.

The company also places significant emphasis on scale and accessibility, recognizing that advanced diagnostics can only create widespread impact if they are practical and broadly available. Blood-based testing is central to this strategy because it allows sophisticated molecular analysis to be delivered through a relatively simple and familiar clinical process. By using blood samples to generate cardiovascular insights, the company aims to make precision diagnostics more compatible with routine healthcare workflows and more accessible across diverse patient populations.

Accessibility has become an increasingly important issue within preventive healthcare. According to the World Health Organization, cardiovascular diseases cause an estimated 17.9 million deaths each year globally, with many cases linked to modifiable risk factors that can potentially be addressed through earlier detection and intervention. Expanding access to scalable preventive tools represents a critical component of reducing long-term disease burden.

Cardio Diagnostics’ vision reflects a broader transformation occurring across medicine as healthcare providers look to move from reactive treatment models toward preventive and precision-based care. By combining expert-led innovation, AI-driven technology, dynamic biomarkers and scalable testing approaches, the company is seeking to redefine how cardiovascular risk and disease are assessed and managed. Its platform is designed not only to provide individualized molecular insights but also to support a healthcare environment where prevention becomes more proactive, data-driven and accessible.

For more information, visit www.CDIO.ai.

NOTE TO INVESTORS: The latest news and updates relating to CDIO are available in the company’s newsroom at https://ibn.fm/CDIO

• GLND secured a five-year drilling agreement with Stampede Drilling for Arctic exploration operations
• The company plans to drill wells targeting multi-billion-barrel hydrocarbon potential in Greenland’s Jameson Land Basin
• These developments position Greenland Energy within one of the North Atlantic’s most promising frontier energy plays

Greenland (NASDAQ: GLND) is accelerating its push into Arctic energy exploration as global demand for new hydrocarbon discoveries continues to grow and traditional resource basins become increasingly mature. With frontier regions returning to focus, Greenland’s Jameson Land Basin is emerging as a potentially significant untapped energy opportunity, and Greenland Energy is positioning itself at the center of that development (ibn.fm/AfUGc).

The company recently announced a five-year drilling agreement with Stampede Drilling Inc. to secure Rig #12, a high-performance drilling rig specifically equipped for Arctic conditions. The agreement supports Greenland Energy’s upcoming drilling campaign in the Jameson Land Basin, where the company plans to drill wells targeting deep hydrocarbon systems across multiple prospective zones.

“Reaching 3,500 meters into the Jameson Land Basin, Greenland Energy will be drilling multi-billion-barrel hydrocarbon potential in one of the North Atlantic’s most promising frontier plays,” the company stated in a recent update. “As work begins on the 2026 drilling program, the target is clear: test the basin’s full hydrocarbon potential and open a new chapter in Arctic energy exploration.”

According to its joint venture partner, 80 Mile PLC, each planned well is expected to reach a minimum depth of 3,500 meters in an effort to delineate the basin’s hydrocarbon potential. The region has been compared geologically to Norway’s prolific Haltenbanken and Barents Sea provinces, both of which have become strategically important energy-producing areas.

Jameson Land spans roughly two million acres in East Greenland and remains largely underexplored despite its significant geological promise. An independent prospective resources report prepared by Sproule ERCE estimated about 13 billion barrels (P10) of gross unrisked recoverable prospective oil resources across the upper levels of the basin, underscoring the scale of the opportunity.

The company is also advancing operational readiness ahead of planned drilling activities in the second part of 2026, subject to regulatory approvals. Greenland Energy is mobilizing heavy equipment to East Greenland and contracted major service providers, including Halliburton and IPT Well Solutions, to support the campaign.

Backing this exploration push, Greenland Energy recently closed a $70 million public offering intended to fund key components of its Jameson Land program, including logistics, procurement, workforce mobilization, and winter-readiness infrastructure. The financing strengthens the company’s ability to execute its exploration strategy as it moves toward drilling operations (ibn.fm/6Fk3r).

Greenland Energy operates within a broader industry trend as supply disruptions, geopolitical instability, and underinvestment in traditional oil basins push energy companies toward frontier exploration regions. Arctic resource development has increasingly gained attention as nations and companies seek long-term supply security and large-scale resource opportunities.

These updates highlight Greenland Energy’s broader mission: to build a publicly traded platform focused on unlocking the hydrocarbon potential of Greenland’s Jameson Land Basin. With drilling preparations advancing, strategic financing secured, and infrastructure partnerships in place, GLND is strategically positioning itself within a high-impact frontier exploration story at a time when global energy markets are increasingly seeking the next major basin opportunity.

For more information, visit the company’s website at www.GreenlandEnergyCo.com.

NOTE TO INVESTORS: The latest news and updates relating to GLND are available in the company’s newsroom at ibn.fm/GLND

Forward-Looking Statements

This communication contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995 and within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained herein other than statements of present or historical fact, including, without limitation, statements regarding Greenland Energy Company’s (the “Company”) future financial performance, business strategy, operations, financial position, estimated revenues and losses, projected costs, prospects, plans, objectives of management, and expected benefits of the Company’s recent business combination, are forward-looking statements. Forward-looking statements are generally identified by the use of words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “project,”

“forecast,” “potential,” “predict,” or the negative of these terms or similar expressions, although not all forward-looking statements contain such identifying words.

These forward-looking statements are based on management’s current expectations, assumptions and beliefs regarding future events and are based on information currently available to the Company. These statements involve a number of risks and uncertainties, many of which are difficult to predict and are beyond the Company’s control, and actual results may differ materially from those expressed or implied by these forward-looking statements. Factors that could cause actual results to differ materially include, among others: (i) Exploration and Geological Risks, including the Company’s status as a development-stage company with no operating history, revenues, or proved reserves; the inherent uncertainty in prospective resource estimates, including that the 13 billion barrel estimate is based on undiscovered accumulations with no certainty of discovery or commercial viability; geological complexity arising from limited seismic data coverage, pervasive igneous intrusions, faulting patterns, and significant Tertiary uplift creating thermal maturity uncertainty; the fact that the basin has never produced a commercial discovery despite decades of study dating back to the 1970s, and a 2008 USGS report stating less than a 10% chance of containing a technically recoverable hydrocarbon accumulation; and high-cost frontier exploration with estimated well costs of $40 million for the first well and $20 million for subsequent wells; (ii) Operational and Environmental Risks, including the challenges of operating in a remote Arctic location with extreme climate, harsh weather, limited daylight, no existing infrastructure, and seasonal access windows for equipment and personnel; drilling hazards such as blowouts, equipment failures, well control events, environmental releases, and accidents inherent in oil and gas operations; reliance on third-party contractors; and climate change scrutiny, as operations in Greenland face increasing opposition from environmental groups and institutional investors due to Arctic drilling concerns; (iii) Regulatory and Political Risks, including the 2021 Greenland drilling moratorium, and while licenses are grandfathered, future regulatory changes could jeopardize operations; geopolitical tensions, including U.S. interest in acquiring Greenland and Greenland’s internal independence movements that could affect operations; permit requirements, as drilling requires Environmental Impact Assessment approval and Field Activities Application approval from Greenlandic authorities; and forfeiture risk, as failure to meet drilling milestones could result in loss of the Company’s right to earn working interests; (iv) Financial and Capital Risks, including significant capital requirements and the need for substantial funding beyond current resources to complete the drilling program; commodity price volatility, as oil, gas, and NGL prices are highly volatile and will heavily influence project viability; a long development timeline during which market conditions may change significantly before potential production, unlike short-cycle shale projects; going concern uncertainty and substantial doubt about the Company’s ability to continue as a going concern without additional financing; and energy transition risk, as global demand for oil may decline due to electric vehicle adoption, renewable energy policies, and changing consumer preferences; and other risks and uncertainties as set forth in the Company’s Prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b)(4) under the Securities Act on April 29, 2026, in the section titled “Risk Factors”.

Forward-looking statements speak only as of the date they are made. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements.

• Across the world, natural resource wealth has played a significant role in shaping political outcomes, particularly in smaller or emerging regions seeking greater autonomy.
• Bougainville has long been associated with significant mineral wealth, particularly copper and gold deposits at the Panguna Mine.
• Numa Numa Resources is working to advance mining development in Bougainville in a way that aligns with local priorities and long-term economic goals.

Small islands with large mineral reserves often face a defining question: Can the wealth beneath the ground help fund political and economic independence above it? In Bougainville, Numa Numa Resources is working within this dynamic, positioning itself in a region where resource development and aspirations for self-determination are closely intertwined.

Across the world, natural resource wealth has played a significant role in shaping political outcomes, particularly in smaller or emerging regions seeking greater autonomy. In some cases, resource revenues have helped finance governance structures, infrastructure, and public services that underpin independence. For example, Norway’s sovereign wealth fund, built from oil revenues, has grown into one of the largest in the world, surpassing $1.4 trillion in assets, demonstrating how resource wealth can support long-term national stability and independence. While Norway is neither a small island nor a newly independent state, this fund illustrates how disciplined resource management can create enduring economic strength.

In developing regions, the relationship between natural resources and independence can be more complex. Timor-Leste, which gained independence in 2002, has relied heavily on oil and gas revenues to fund government operations. According to the International Monetary Fund, petroleum revenues have historically accounted for the majority of government income in Timor-Leste, underscoring the critical role resource wealth can play in sustaining a young nation. However, such dependence also highlights the importance of diversification and careful management to avoid volatility.

Bougainville presents a unique case within this broader context. The autonomous region of Papua New Guinea has long been associated with significant mineral wealth, particularly copper and gold deposits at the Panguna Mine. During its operation, Panguna was one of the largest copper mines in the world and contributed substantially to Papua New Guinea’s economy, with the mine accounting for approximately 45% of the country’s export earnings at its peak. Yet disputes over the distribution of these benefits and environmental impacts contributed to a civil conflict that lasted from 1988 to 1998.

Since the Bougainville Peace Agreement in 2001, the region has taken steps toward greater autonomy. In 2019, Bougainville held a nonbinding referendum in which 97.7% of voters supported independence from Papua New Guinea. While the final political outcome remains subject to negotiation with Papua New Guinea, the referendum underscores the strength of local aspirations for self-governance.

Economic viability is a central consideration in any independence process, and resource wealth often plays a key role in that equation. Copper is increasingly viewed as a strategic resource due to its importance in renewable energy systems and electrification. The International Energy Agency projects that demand for copper is expected to rise significantly as the global energy transition accelerates. For regions such as Bougainville, this creates both an opportunity and a challenge: how to responsibly develop resources in a way that supports long-term prosperity.

In addition to traditional resource development, emerging financial concepts have introduced new ways of thinking about how underground wealth might be leveraged. Tokenization, for example, refers to the creation of digital assets backed by real-world resources. While still an evolving concept, the World Economic Forum has noted that asset tokenization could improve liquidity and access to capital by allowing investors to participate in previously illiquid assets. In theory, this could include mineral resources, although practical implementation would require robust governance, transparency and regulatory frameworks. Such approaches remain speculative but can illustrate how innovation could intersect with resource-based economies.

Within this broader landscape, Numa Numa Resources is working to advance mining development in Bougainville in a way that aligns with local priorities and long-term economic goals. Numa Numa emphasizes collaboration with landowners and adherence to Bougainville’s legal and cultural framework, particularly the recognition of customary land rights. This approach reflects lessons from the region’s history, where tensions over land and resource ownership played a central role in past conflict.

By focusing on responsible development, Numa Numa Resources aims to help unlock Bougainville’s mineral potential while supporting economic foundations that could contribute to greater self-sufficiency. The company’s engagement with local stakeholders is intended to ensure that any future mining activities provide tangible benefits to communities, including infrastructure, employment, and revenue generation.

As Bougainville continues to navigate its political future, the relationship between resource wealth and independence remains a central theme. The region’s experience highlights both the promise and the complexity of relying on natural resources as a pathway to self-determination. Success will depend not only on the presence of valuable minerals but also on how those resources are managed, shared, and integrated into a broader economic strategy.

Numa Numa Resources is operating within this evolving environment, where economic development, governance and community engagement are closely linked. While the path forward for Bougainville is still being defined, the interplay between resource wealth and independence will likely continue to shape the region’s trajectory for years to come.

For more information, visit www.NumaNumaResources.com.

NOTE TO INVESTORS: The latest news and updates relating to Numa Numa are available in the company’s newsroom at https://ibn.fm/NUMA

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

• BOXABL has appointed technology executive Shan Palaniappan as chief technology officer as it expands automation, software and AI capabilities across operations.
• The company is pursuing a proposed merger with FG Merger II Corp. (NASDAQ: FGMC), with the combined company expected to trade under the ticker Nasdaq: BXBL.
• BOXABL has already produced more than 800 housing units from its Las Vegas manufacturing facility and is targeting multiple residential and commercial market segments.
• The company’s modular system is designed to support scalable deployment for single-family homes, multifamily housing, workforce accommodations, and hospitality projects.
• Management sees long-term opportunity in combining home production with recurring service revenues tied to financing, insurance, and maintenance.

BOXABL, an innovative technology construction company on a mission to solve the global affordable housing crisis, is attempting to apply manufacturing principles more commonly associated with the automotive and consumer electronics industries to one of the least standardized sectors of the American economy: residential construction.

Headquartered in Las Vegas, Nevada, the company is building a factory-based housing platform centered on modular, foldable residential units that can be transported on standard trailers and quickly assembled on-site. BOXABL’s broader objective is to shift homebuilding away from fragmented field construction toward a more standardized production model.

The company is currently advancing through an S-4 registration process tied to its previously announced merger agreement with FG Merger II Corp., a special purpose acquisition company trading on Nasdaq under the ticker FGMC. Once the transaction is completed, the combined entity is expected to trade as BXBL on Nasdaq. The transaction represents a test of whether factory-built housing can move beyond niche modular applications and scale into a larger share of mainstream residential construction.

BOXABL’s strategy is based upon flexibility. BOXABL says its modular units are designed to stack and connect, allowing them to be adapted for townhomes, apartment-style developments, workforce housing, hospitality projects, and larger single-family residences.

The company’s basic flagship product is the Casita, a 361-square-foot modular studio-style home designed to arrive largely finished from the factory. Units include kitchens, bathrooms, electrical systems and plumbing infrastructure before transport. Once delivered, the structures unfold on-site into completed living spaces.

However, the company has since expanded the platform into additional configurations, including one-bedroom and two-bedroom layouts, while also developing the Baby Box, a smaller unit built to RV standards for less complex installations.

The company operates from a roughly 400,000-square-foot manufacturing facility in Las Vegas, where management says more than 800 homes have been produced to date. Unlike conventional homebuilders that rely heavily on subcontractors and project-specific workflows, BOXABL is attempting to standardize production inside a controlled manufacturing environment, with technology and design that differentiates it from previous manufactured home operations. The company believes this will improve construction speed, reduce defects, and lower overall costs through repeatable processes and automation.

That emphasis on technology was reinforced in March when BOXABL announced the appointment of Shanmugam “Shan” Palaniappan as chief technology officer. Palaniappan previously held engineering and technology leadership positions at companies including Salesforce, Demandware, DataRobot and Sagent. According to BOXABL, his mandate includes expanding software infrastructure, factory automation and AI-driven operational systems.

Management says the company is working toward integrating real-time analytics into areas such as sales forecasting, production planning, land feasibility analysis and supply-chain management. The goal is to improve throughput while reducing inefficiencies across the manufacturing process.

The company’s strategy reflects a broader trend across industrial sectors where software increasingly shapes operational execution. In housing construction, where productivity growth has lagged other industries for decades, proponents of factory-built systems argue that automation and standardization may help offset labor constraints and cost inflation.

BOXABL is entering a market with substantial demand drivers. The company estimates the broader U.S. housing market represents roughly $2.2 trillion in addressable demand, citing a combination of housing shortages and ongoing affordability challenges. Industry estimates referenced by the company point to a national housing shortfall of more than four million homes.

Management also identifies regulatory and permitting complexity as structural contributors to rising construction costs. By standardizing portions of the building process within a factory setting, BOXABL believes it can reduce variability and improve cost predictability.

Within that broader market, the company is initially focused on modular and manufactured housing segments. BOXABL estimates its immediate obtainable market at approximately $1 billion annually based on projected single-factory production capacity and average unit pricing.

The company’s business model extends beyond unit sales alone. Management has discussed developing ancillary service revenue opportunities tied to financing, insurance, maintenance and installation services. That approach could provide higher-margin recurring revenue streams alongside home production.

For more information, visit the company’s website at www.Boxabl.com.

• Research supports the urgent need for more effective tools to identify the risk of cardiovascular disease earlier and guide personalized intervention strategies.
• Cardio Diagnostics’ solutions reflect a strategy aimed at addressing cardiovascular disease across multiple stages of care.
• This emphasis on prevention aligns with growing recognition that earlier intervention can significantly improve long-term outcomes.

Most people are aware that cardiovascular disease (“CVD”) is the leading cause of death in the United States; what they might not know is that an estimated 80% of those cases are considered preventable through earlier detection and proactive management of key risk factors. This highlights the urgent need for more effective tools that can identify risk earlier and guide personalized intervention strategies. Cardio Diagnostics Holdings (NASDAQ: CDIO) is rising to the challenge by developing a suite of clinical, population health and biopharma solutions designed to leverage artificial intelligence (“AI”), epigenetics and genetics to improve cardiovascular disease prevention, detection and management.

The company’s platform is built around the integration of genetic and epigenetic biomarkers with AI-driven analytics to provide personalized cardiovascular insights from blood-based testing. Cardio Diagnostics currently offers two clinical solutions, Epi+Gen CHD(TM) and PrecisionCHD(TM), as well as a population health and biopharma offerings, HeartRisk(TM) and CardioInnovate360(TM), respectively. Collectively, these solutions reflect a strategy aimed at addressing cardiovascular disease across multiple stages of care, from early detection and prevention to therapeutic development and population-level risk management.

One of the company’s flagship clinical offerings, Epi+Gen CHD is designed to assess an individual’s three-year risk of having a coronary heart disease event, including a heart attack, by analyzing both epigenetic and genetic biomarkers. Unlike traditional cardiovascular assessments that often rely heavily on demographic data or standard laboratory measurements, Epi+Gen CHD seeks to capture a more comprehensive molecular profile. 

CVD is largely driven by lifestyle and environment, not genetics. Therefore, the inclusion of epigenetic markers such as DNA methylation patterns is particularly significant because these biomarkers can reflect the influence of lifestyle, environmental exposures and disease processes on gene expression over time. By integrating these biomarkers with AI-powered analysis, Cardio Diagnostics is working to improve the precision and personalization of cardiovascular assessment.

The company’s second clinical solution, PrecisionCHD, is designed to aid in the diagnosis of coronary heart disease when there is clinical suspicion of disease. This preventive orientation reflects a broader shift within healthcare toward identifying disease earlier and intervening before disease progression leads to severe outcomes such as heart attacks. PrecisionCHD is intended to support physicians and patients in making more informed preventive care decisions based on personalized molecular insights.

This emphasis on prevention aligns with growing recognition that earlier intervention can significantly improve long-term outcomes. The Centers for Disease Control and Prevention notes that controlling major risk factors such as high blood pressure, high cholesterol, diabetes and smoking can substantially reduce the likelihood of cardiovascular events. However, many individuals remain unaware of their underlying risk until symptoms appear. Clinical solutions such as Epi+Gen CHD and PrecisionCHD are designed to help close that gap by identifying predisposition earlier in the disease continuum.

Beyond individual clinical diagnostics, Cardio Diagnostics is also targeting broader population health applications through HeartRisk. This solution is designed to support employers, health systems and population health organizations by helping identify cardiovascular risk across larger groups of individuals. Population health initiatives have become increasingly important as healthcare systems seek to reduce long-term costs and improve preventive care outcomes at scale.

The economic implications of cardiovascular disease further reinforce the value of such approaches. The CDC reports that heart disease and stroke together cost the United States hundreds of billions of dollars annually in healthcare expenses and lost productivity. Earlier risk identification and targeted preventive interventions could help reduce some of this burden by minimizing avoidable hospitalizations and advanced disease complications.

CardioInnovate360 expands the Cardio Diagnostics’ reach into the biopharma and research sectors. According to CDIO, this solution is intended to support pharmaceutical and biotechnology companies through biomarker discovery, drug development and Precision Medicine applications. The integration of AI with multi-omic biomarker analysis has the potential to enhance understanding of disease mechanisms, improve patient stratification and support more targeted therapeutic development.

Artificial intelligence plays a central role across all of the company’s offerings. AI systems are capable of analyzing large and complex biological datasets to identify patterns and relationships that may not be apparent through traditional analytical methods. Cardio Diagnostics’ solutions are built around this principle, using machine learning to help transform molecular data into clinically actionable information.

The company’s emphasis on blood-based testing and scalable analytics also supports broader accessibility. Blood tests are already deeply integrated into routine healthcare workflows, making them practical tools for widespread testing and monitoring. By combining familiar clinical processes with advanced AI-driven analysis, Cardio Diagnostics is seeking to bridge the gap between cutting-edge molecular science and real-world clinical adoption.

As cardiovascular disease continues to impact millions of people worldwide, the need for more personalized and preventive approaches remains substantial. Through Epi+Gen CHD, PrecisionCHD, HeartRisk and CardioInnovate360, Cardio Diagnostics is building a portfolio of solutions intended to address cardiovascular disease across clinical care, population health and therapeutic innovation. By leveraging AI, genetics and epigenetics, the company is positioning itself within the growing movement toward precision cardiovascular medicine and earlier, more proactive disease management.

For more information, visit www.CDIO.ai.

NOTE TO INVESTORS: The latest news and updates relating to CDIO are available in the company’s newsroom at https://ibn.fm/CDIO

• The company’s proprietary FASForm(TM) platform advancing new approach to coal.
• Frontieras processes coal into multiple commercially valuable outputs, tied to markets estimated at more than $2 trillion.
• Core thesis is that coal’s largest missed opportunity lies not in power generation alone but in its unrealized value as a diversified industrial resource.

Global demand for energy is accelerating at a historic pace as artificial intelligence (“AI”), advanced manufacturing and industrial expansion place increasing pressure on existing power systems. Governments and industries are exploring nearly every available energy source to meet that demand, yet one of the world’s most abundant and energy-dense resources remains widely overlooked and underutilized.

Frontieras North America is advancing a new approach to coal through its proprietary FASForm(TM) platform, which converts coal into fuels, hydrogen and industrial materials, positioning the resource as a multi-output industrial feedstock capable of supporting modern energy and manufacturing markets.

Coal has served as a foundational global energy source since the Industrial Revolution and remains the world’s largest source of electricity generation more than 200 years later, according to the International Energy Agency. Coal supply is ample, with global proven recoverable coal reserves estimated at approximately 1.16 trillion short tons, enough to support production for more than a century at current consumption rates. Few energy resources match coal’s combination of scale, availability and existing infrastructure.

Yet despite those fundamentals, the coal industry has spent years under pressure from shifting energy policies, rising operational costs and the rapid expansion of alternative energy investment. Coal-fired power plants across parts of the United States and Europe have been retired or scheduled for closure, while investment in new coal technologies slowed substantially during the global transition toward renewable energy systems. Rising oil prices and supply volatility have further complicated global energy markets, exposing vulnerabilities in fuel supply chains and increasing pressure on governments and industries to secure stable domestic energy resources.

Within that environment, Frontieras North America is advancing a fundamentally different approach to coal utilization. Rather than treating coal as a single-use combustion fuel, the company positions it as a multi-output industrial resource capable of producing fuels, hydrogen, industrial carbon products and chemical feedstocks simultaneously. Matthew McKean, Frontieras cofounder and CEO, describes the company’s FASForm Solid Carbon Fractionation technology as “a patented, zero-waste process that takes coal and disassembles it at the molecular level into multiple higher-value products: ultra-low sulfur diesel, naphtha, purified solid carbon fuel, hydrogen, ammonium sulfate fertilizer, and industrial chemicals.

“No combustion. No emissions from the process itself,” McKean continues. “Six product streams from a single feedstock, produced entirely from American resources on American soil. This is what it looks like when you stop apologizing for coal and start unlocking what coal actually is: the most energy-dense, abundant, accessible hydrocarbon resource on the planet, sitting under our feet, waiting to be fractionated into the fuels, fertilizers and chemicals the world is right now scrambling to secure.”

Conventional coal use extracts only a portion of the resource’s broader value by burning it solely for heat or electricity generation. Frontieras instead fractionates coal into multiple commercially valuable outputs. The scale of the markets tied to those products is substantial, estimated to be more than $2 trillion. Diesel remains one of the world’s foundational transportation and industrial fuels, powering freight logistics, construction equipment and heavy machinery globally. Jet fuel demand continues to expand alongside commercial aviation activity.

Hydrogen plays a critical role in refining, industrial manufacturing and chemicals production, while naphtha serves as a core petrochemical feedstock used in plastics, synthetic fibers and industrial materials manufacturing. In addition, Frontieras’s FASCarbon(TM) further expands the company’s reach into industrial materials sectors. Frontieras describes the product as a virtually sulfur-free technical carbon that can serve as a replacement carbon source in steel manufacturing and industrial thermal applications, burning hotter and cleaner than conventional petroleum coke while supporting steel-coke and industrial heating markets that rely on carbon-intensive feedstocks. The company also integrates fertilizer and industrial chemical production into its process. This multi-output structure allows one facility to participate across transportation, industrial manufacturing, agriculture and materials markets simultaneously.

Frontieras’s thesis is that coal’s largest missed opportunity lies not in power generation alone but in its unrealized value as a diversified industrial resource. Coal contains hydrocarbons, carbon compounds and chemical elements that support fuels, manufacturing inputs, fertilizer production and industrial materials. The company’s modern processing technology unlocks those components at commercial scale while operating as a closed-loop system that captures and repurposes process byproducts.

As energy demand continues rising alongside industrial expansion, AI infrastructure growth and manufacturing activity, systems capable of delivering reliable fuel and material outputs at scale are becoming increasingly important. Frontieras North America is positioning itself within that landscape by redefining how coal is processed and utilized. Through FASForm, the company is establishing a model in which coal operates not as a declining commodity but as a high-value industrial feedstock capable of supporting multiple trillion-dollar global markets through a single integrated process.

For more information about Frontieras, visit the company’s website at www.Frontieras.com.

NOTE TO INVESTORS: The latest news and updates relating to Frontieras are available in the company’s newsroom at https://ibn.fm/Frontieras